GlaxoSmithKline PLC Director/PDMR Shareholding (5287P)
08 Febrero 2019 - 6:16AM
UK Regulatory
TIDMGSK
RNS Number : 5287P
GlaxoSmithKline PLC
08 February 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=================================================================================
a) Name Mr N Hirons
==== ========================= ======================================================
b) Position/status SVP, Global Ethics & Compliance
==== ========================= ======================================================
c) Initial notification/ Initial notification
amendment
==== ========================= ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =================================================================================
a) Name GlaxoSmithKline plc
==== ========================= ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ========================= ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ========================= ======================================================
b) Nature of the The exercise of options over 4,600 ADSs,
transaction granted on 17 February 2009 under the GlaxoSmithKline
Share Option Plan.
==== ========================= ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s) $33.4200 1,608 (Non-Qualified Stock
Option)
---------------------------
$33.4200 2,992 (Incentive Stock
Option)
---------------------------
==== ========================= ======================================================
d) Aggregated information
Aggregated volume
Price
4,600
$33.4200
============================== ======================================================
e) Date of the transaction 2019-02-07
==== ========================= ======================================================
f) Place of the n/a
transaction
==== ========================= ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
=========================================================================
a) Name Mr N Hirons
==== ========================= ==============================================
b) Position/status SVP, Global Ethics & Compliance
==== ========================= ==============================================
c) Initial notification/ Initial notification
amendment
==== ========================= ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================
a) Name GlaxoSmithKline plc
==== ========================= ==============================================
b) LEI 5493000HZTVUYLO1D793
==== ========================= ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ========================= ==============================================
b) Nature of the The sale of 4,600 ADSs, following the exercise
transaction of options granted on 17 February 2009
under the GlaxoSmithKline Share Option
Plan.
==== ========================= ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s) $41.0800 1,608 (Non-Qualified Stock
Option)
---------------------------
$41.0800 2,992 (Incentive Stock
Option)
---------------------------
==== ========================= ==============================================
d) Aggregated information
Aggregated volume
Price
4,600
$41.0800
============================== ==============================================
e) Date of the transaction 2019-02-07
==== ========================= ==============================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ========================= ==============================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHLVLFBKLFFBBL
(END) Dow Jones Newswires
February 08, 2019 07:16 ET (12:16 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
